TB-is an ___ ___ disease caused by ____ ____
-from 1985-1993 there was in increase in cases
due to: ___ epidemic, ___ from countries were tb is ___, and trasmission in ___ settings (____ centers, ___, ___ ___)
-even so TB continues to be major problem in US, especially __ __ __ __ of TB (____)
airborne communicable, mycobacterium tuberulosis
Transmission: TB is spread from ___ to ___ through the ___
person to person, air
Process of infection:
1) ptns with active pulmonary tuberulosis aerosolize respiratory droplets when ___ or ____
2) as water content of secretions ____, a small residue of particulate matter that contains ___ ___ __ called __ __ is formed
3) these droplets remain __ for ___ periods of time
4) when inhaled, most of these droplet nuclei are deoposited in the __ __ __, however some may reach the ____ of the __ to __ ___
5) the host immune system responds with ___ (usually ___ ___) –> if this is unsuccessful, a small primary __ infection develops at this site
6) over the next few __ the bacilli ___ and ___
7) the initial spread is the the __ __ __ and later throughout the ___–> ________ ______ is responsible for spread throughout the body
8) host immunity deveops through ____ mechanisms and is usually sufficent to control the primary infection after ___ weeks –> usually the exposure is __ and the dx is ___ in this matter
- ptns have ____ symptoms and may not be diagnosted
9) if host fails to develop immunity to primary infection, __ __ tuberculosis results
10) the usual rxn is for host immunity to creat a ____ rxn around the bacilli after prim infection; therefore a ___ ___ infection is prevented
11) the organism can remain __ for ___
* factors that cause reactivation?
1) coughing or sneezing
2) evaporates, viable bacilli nuclei, droplet nuclie
3) viable, variable
4) upper respiratory tract, alveoli, mid to lower lung
5) phagocytes (alveolar machrophages), pulmonary infection
6) weeks, multiply and disemminate
7) hylar lymph nodes, lung; lymphohematogenous dissemination
8) cell-mediated, 4-6, small, controlled
- minimal
9) progressive primary
10) granulomatous, second primary
11) dormant, years
* 1.HIV infection
2. immunosuppressive therapy
3. prolonged corticosterroid therapy
4. end stage renal dx
5. radiation to thorax
6. malnutrition
7. silicosis or pneumonconiosis
Pathogenesis:
1) most primary infections are ____
* althose these people test ___ on the tb skin test, they do not have ___ tb and are __ ___
* bacilli may persis in the host for ___ w/o producing ___ TB => known as ___ ___
2) the ___ is the typical early lesion, usually occuring in the ___ and the ___ site of infection
* it is an intense ____,____ rxn that isolates the billi
3) Healing that this stage may result in ___ and ___ which a __ __ visible on the __ ___
4) future _____ of the ___ infection is the usual cause of active TB -> ptns who develop this become _____
1) subclinical
* positive, active, not infectious
* decades, active, tb infection
2) granuloma, lung, original
* necrotizing, inflam
3) scarring and calcification, residual lesion, chest radiograph
4) reactivation, latent; symptomatic
Clinical symp of TB:
-chronic cough
-few, extensive
*fever, night sweats, wt loss
central pulmonary necrosis
cavitation in lung
caseation necrosis
exudative lung lesions
hemoptysis
-any organ
Screening methods: diagnosis is made through combination of __ ___ and evaluation of ___ ___ , ___ ___, and ___ ___
PPD screening, chest radiograph, sputum culture, clinical symptoms
PPD skin test and anergy testing:
Chest radiograph:
-is the ___ method to identify persons w/ __ ___ TB when risk for infection ___ or consequences of _____ disease are severe as in __ __ and ____
preferred current pulmonary high undiagnosed homeless shelters and prisons
Treatment of active disease:
-concomitant, 24 months
-susceptibility, INH resistance,HIV, treatment, infection, age
-hepatitis, hepatotoxicity
leukopenia, thrombocytotosis
GI disturbances, nephrotoxicity, ototoxicity
*liver; drug meta, bleeding, infection
-Isoniazid (INH), rifampin (RIF), septomycin, pyrazinamimne, ethambutol
*self medication
*compliance, long, treatment
*directly observed thearpy (DOT), discharged, hospital
-MRTB
*85%, short (4-16 weeks)
Dental considerations: management depends on ___ of the dx
1) ptns w/ recent positive PPD skin test: ptns require ____ by ___ to rule out ___ dx
* these ptns have been infected with m. tubercu in the ___
* most never develop __ dx
* ptns placed on __ __ therapy for __ to __ months, are not ___, and can be treated ____
status
1) evaluation by physican, active
* past
* active
* preventive INH, 6-12, active, normally
Dent consideration: ptns with signs or symptoms of active TB:
dental considerations: ptn with hx of tuberculosis:
effectivness, treatment
oral complications of TB: